FilingReader Intelligence
J.B. Chemicals reports 12% revenue growth to Rs3,918cr
July 11, 2025 at 07:09 PM UTC•By FilingReader AI
J.B. Chemicals & Pharmaceuticals reported total revenues of Rs3,918 crores for FY25, a 12% year-on-year growth, with operating EBITDA exceeding Rs1,000 crore, marking a 16% increase.
Domestic formulations grew 20% to Rs2,269 crores. The company highlighted its acquisition of a controlling stake from KKR by Torrent Pharmaceuticals Limited and its focus on chronic therapies.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:JBCHEPHARM•Bombay Stock Exchange
News Alerts
Get instant email alerts when J.B. Chemicals & Pharmaceuticals publishes news
Free account required • Unsubscribe anytime